Sandimmun Neoral, Trinklösung
7680526570169
CH-52657
Trinklösung
Associated product:
SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
1 / 3
google
Article details
- Package size
- 50
- Selling units
- 50
- Measure
- ml
- Galenic form
- Trinklösung
- Galenic group
- Unknown
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
94.7 MG | Substance | HBESI |
|
(N/A)
|
94.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
383.7 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTOX |
Reimbursement information
Public price
CHF 205.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1995
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 52657
- Drug name
- Sandimmun Neoral, Trinklösung
- Galenic form
- LSOR
- ATC Code
- L04AD01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 16/05/1994
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
- Description (DE)
- SANDIMMUN NEORAL Trink Lös 100 mg/ml 50 ml
- Market launch
- 16/05/1994
- Narcotic (BTM)
- No